Related Experiment Videos
GM-CSF treatment of a patient with hairy-cell leukaemia. A potentially effective treatment?
European Journal of Haematology
|October 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
The British journal of dermatology·2013
Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
Danish medical bulletin·2006
Soluble CD163: a marker molecule for monocyte/macrophage activity in disease.
Scandinavian journal of clinical and laboratory investigation. Supplementum·2003
Association between deficiency of mannose-binding lectin and severe infections after chemotherapy.
Lancet (London, England)·2001
[Invasive aspergillosis in hematological patients].
Ugeskrift for laeger·2000
Chimeric Antigen Receptor T-Cell Therapy in T Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
European journal of haematology·2026
Elevated Risks for Depression and Anxiety Following Diagnosis of Multiple Myeloma.
European journal of haematology·2026
BCMA-Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management.
European journal of haematology·2026
Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B-Cell Lymphoma.
European journal of haematology·2026
Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First-Line Treatment in Patients With Newly Diagnosed Non-Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study.
European journal of haematology·2026